List view / Grid view
1 December 2015 | By Dolomite
Dolomite, part of the Blacktrace group of companies, is celebrating a decade of excellence in the design and manufacture of novel, high quality microfluidic products, including individual components such as pumps, chips, connectors, temperature controllers and sensors, software solutions and complete microfluidic systems...
1 December 2015 | By Black Swan Analysis
Research and Markets has announced the addition of the "Epiomic Epidemiology Series: Atopic Dermatitis Forecast in 17 Major Markets 2015-2025" report to their offering...
1 December 2015 | By Victoria White
GlobalData says the rising number of opioid-induced constipation sufferers is largely down to overall population increase...
1 December 2015 | By Victoria White
The novel, oral small molecule inhibitor of VAP-1 is a cell-adhesion molecule that may be effective in the treatment of inflammatory diseases...
1 December 2015 | By Victoria White
The assay has been selected by the International Breast Cancer Study Group (IBCSG) and the Breast International Group (BIG) to be part of a trial studying the effects of palbociclib in breast cancer...
1 December 2015 | By Victoria White
These first vaccine doses will be available to implement one dose of IPV for all infants in the country...
1 December 2015 | By Victoria White
An official decision on the Ophran Drug Designation is expected from the European Commission in December...
1 December 2015 | By Victoria White
Empliciti (elotuzumab) has been approved as combination therapy with Revlimid (lenalidomide) and dexamethasone (ERd) in patients who have received one to three prior therapies.
30 November 2015 | By Victoria White
Stelara (ustekinumab), approved for the treatment of plaque psoriasis and active psoriatic arthritis in many countries, is a human monoclonal antibody that targets interleukin (IL)-12 and IL-23 cytokines...
30 November 2015 | By
The European Medicines Agency (EMA) has accepted for review, the marketing authorisation application (MAA) for Helsinn Group’s anamorelin HCI...
27 November 2015 | By Victoria White
Sirukumab is an investigational human anti-IL-6 monoclonal antibody that selectively binds with high affinity to the IL-6 cytokine...
27 November 2015 | By Victoria White
Lannett has acquired KU from UCB for a total consideration of approximately US$1.23 billion...
27 November 2015 | By Victoria White
This patent protects the topical use of RP0217 for the treatment or prevention of respiratory and gastrointestinal inflammatory disorders...
27 November 2015 | By Victoria White
CPhI and P-MEC India will return to the Bombay Convention and Exhibition Centre, Mumbai, India from 1 to 3 December 2015...
26 November 2015 | By Victoria White
Elocta will be the first haemophilia A treatment in the EU to offer prolonged protection against bleeding episodes with prophylactic injections every three to five days...
